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We used data from a large cohort study of Canadian women to assess the association of meat intake and dietary intake of iron and
haem iron with risk of endometrial cancer. Among 34148 women with an intact uterus at baseline and followed for a mean of 16.4
years, we identified 426 incident endometrial cancer cases. Data from a food frequency questionnaire administered at baseline were
used to calculate intake of all meats, red meat, total dietary iron, iron from meat, haem iron, and non-haem iron. Analyses were
carried out using Cox proportional hazards models with adjustment for known risk factors and covariates. We found no association
of intake of meat or any of the dietary iron-related variables with risk of endometrial cancer.
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Endometrial cancer is largely a malady of affluent, developed
societies, showing a more than 10-fold variation between high- and
low-incidence countries (Parkin et al, 1999). Major risk factors
include obesity and oestrogen replacement therapy (Grady et al,
1995; Kaaks et al, 2002; Persson and Adami, 2002), and recent
work suggests that insulin resistance, hyperinsulinemia, and
diabetes may also play a role in the disease (Soliman et al, 2006;
Cust et al, 2007; Friberg et al, 2007). There is limited evidence that
a high intake of red meat may increase risk (Terry et al, 2002a;
Bandera et al, 2007).
A possible association of red meat intake with endometrial
cancer risk may reflect a role of haem iron, which derives mainly
from red meat and which has greater bioavailability than inorganic
iron (Huang, 2003). Free iron is a pro-oxidant and can catalyse
lipid peroxidation and DNA damage (McCord, 1998; Huang, 2003).
The association of the interrelated conditions of insulin resistance,
hyperinsulinemia, and diabetes with endometrial cancer risk also
suggests a possible role of excess iron intake or elevated iron stores
with endometrial cancer, as these conditions have been linked to
excess body iron stores (Tuomainen et al, 1997; Fernandez-Real
et al, 1998; Fernandez-Real et al, 2002; Jehn et al, 2004).
Furthermore, elevated iron stores are associated with increased
risk of type II diabetes in healthy women, independent of known
risk factors (Jiang et al, 2004).
Given that few cohort studies have examined the association of
meat intake with risk of endometrial cancer (Zheng et al, 1995),
and no studies have examined the effects of dietary iron or haem
iron intake, we used data from a large cohort study of Canadian
women to assess intake of meat, red meat, total iron, and haem
iron in relation to endometrial cancer risk. In addition, we
explored potential joint effects of iron intake with known risk
factors for endometrial cancer.
MATERIALS AND METHODS
Study population
The present analysis was conducted in the Canadian National
Breast Screening Study (NBSS), a randomised controlled trial of
screening for breast cancer, which has been described in detail
elsewhere (Miller et al, 1992; Terry et al, 2002b). In brief, 89835
women aged 40–59 were recruited from the general Canadian
population between 1980 and 1985. On enrollment into the study,
information was obtained from participants on demographic,
hormonal, and reproductive characteristics, using a self-administered
lifestyle questionnaire. Starting in 1982, a self-administered food
frequency questionnaire (FFQ), designed to estimate energy
and nutrient intake, was distributed to all new attendees at all
screening centres and to women returning to the screening centres
for rescreening (Jain et al, 1982). The FFQ elicited information on
usual portion size and consumption of 86 food items and included
photographs of portion sizes to assist respondents in quantifying
intake. A total of 49654 dietary questionnaires were returned and
were available for analysis. After exclusion of 14906 women who
reported having had a hysterectomy and women whose calorie
intake was greater or less than 3 standard deviations from the
mean (o730 or 46485kcal/day), or whose body mass index (BMI)
was o15 or 450kgm
 2, a total of 34148 women were available
for analysis.
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were ascertained, respectively, by means of computerised record
linkages to the Canadian Cancer Database and to the National
Mortality Database. The linkages to the databases yielded data on
cancer incidence and mortality to 31 December, 2000 for women
in Ontario, 31 December, 1998 for women in Quebec, and 31
December, 1999 for women in other provinces. For the present
analyses, study participants were considered at risk from their date
of enrollment until the date of diagnosis of their endometrial
cancer, termination of follow-up (the date to which cancer
incidence data were available for women in the corresponding
province) or death, whichever occurred first. During an average of
16.4 years of follow-up of the dietary cohort, we identified 426
incident endometrial cancer cases.
Data from the FFQ were used to calculate total dietary iron
intake using a database described elsewhere (Jain et al, 1982). The
values for iron intake presented here are for dietary sources alone,
because data on iron supplements were not collected. Total intake
of meat iron was calculated from the reported intake of 22 meat
items and 2 mixed dishes containing meat. Haem iron intake was
computed by two methods, using different proportions for haem
iron from different types of meat: 69% for beef; 39% for pork ham,
bacon, pork-based luncheon meats, and veal; 26% for chicken and
fish; and 21% for liver, following Balder et al (2006), and,
alternatively, using 40% as the average proportion of haem iron in
all meats, following Lee et al (2004). Results were similar for
both methods, and we present data using the first approach. In
addition, we assessed risk in association with intake of all meats,
red meat, and non-haem iron. All meat- and iron-related variables
were calorie-adjusted using the residuals method (Willett and
Stampfer, 1986).
Statistical analysis
Cox proportional hazards models (using age as the time scale)
were used to estimate hazard ratios (HR) and 95% confidence
intervals (CI) for the association between meat intake and iron
intake and endometrial cancer risk. Quintiles of meat- and iron-
related variables were constructed based on their distribution in
the total population. All multivariate models included the
following covariates: BMI (kgm
 2) (continuous); menopausal
status (pre-, peri-, postmenopausal); parity (nulliparous, 1–2, 3–
4, 5þ live births); age at menarche (continuous); duration of oral
contraceptive use (never, 1–11 months, 12–35 months, 36–71
months, 72þ months); duration of hormone replacement use
(never, 1–11 months, 12–59 months, 60–119 months, 120þ
months); total caloric intake (continuous); intake of raw vegetables
(continuous); alcohol intake (in grams–continuous); physical
activity (vigorous, other); and education (three levels). Addition of
indicator variables for screening centre (1–15) and randomisation
group in the original screening trial (intervention/usual care) did
not affect the risk estimates, and therefore, these variables were
omitted. Because an effect of iron or haem iron intake could be
confounded by intake of other dietary constituents with which they
are correlated, we included important food items (red meat, all
meat, vegetables, raw vegetables) in additional models. Inclusion
of these variables did not affect the risk estimates for iron or haem
iron, and as a result they are not included in the final models. To
test for trends in risk with increasing levels of the exposures of
interest, we assigned the median value for each quintile and then
fitted the medians as a continuous variable in the risk models. We
then evaluated the statistical significance of the corresponding
coefficient using the Wald test (Rothman and Greenland, 1998). In
additional analyses, we also treated iron-related variables as
continuous variables. As early symptoms of the disease might
result in dietary change, we repeated the main analyses, excluding
cases diagnosed during the first 3 years of follow-up.
RESULTS
Cases tended to be older than non-cases, had a higher mean BMI,
had lower parity, were more likely to be postmenopausal and to
have used hormone replacement therapy, and were less likely to
have used oral contraceptives, compared with non-cases (Table 1).
Body mass index and duration of hormone replacement use
showed dose–response relationships with endometrial cancer risk,
and parity and duration of oral contraceptive use were inversely
associated with risk (data not shown; see Silvera et al, 2005:
Table 1). Cases and non-cases were similar in terms of age at first
live birth, smoking status (as well as intensity and duration of
smoking), and alcohol consumption.
In both age- and multivariate-adjusted models, none of the meat
or iron-related variables was associated with risk of endometrial
cancer (Table 2). For all variables except non- haem iron, HRs for
the highest quintiles of exposure relative to the lowest quintile
were below 1.0, but there was no trend over increasing quintiles
and none of the point estimates was statistically significant. For
non- haem iron intake, some HRs were elevated, but, again, none
was statistically significant and there was no clear trend. Similar
results were obtained when iron and meat intake were analysed as
continuous variables (data not shown). When cases diagnosed
during the first 3 years of follow-up were excluded (n¼53), the
patterns were similar to those described above, and no associations
or trends were seen with any of the six variables.
There was no association between haem iron intake and
endometrial cancer risk within strata of BMI, hormone replacement
therapy use (ever or never), or menopausal status (pre- or
postmenopausal). The results for meat-related variables and the
other iron-related variables were similar (data not shown).
DISCUSSION
The present analysis showed no association between intake of meat
or red meat or dietary intake of iron, haem iron, iron from meat
Table 1 Baseline characteristics of the study population by outcome
Factor
Incident endometrial
cancer cases (n¼426)
Non-cases
(n¼33722)
Mean age at baseline
(years)
50.0 (5.4) 48.0 (5.6)
Mean BMI (kgm
 2) 27.0 (5.9) 24.7 (4.1)
Mean age at first live
birth
a
24.8 (4.8) 24.7 (4.8)
Parity (%)
Nulliparous 21.8 16.1
1–2 36.6 37.0
3–4 34.7 37.7
5+ 6.8 9.3
Postmenopausal (%) 41.2 33.6
Cigarette smoking
Never 55.6 53.5
Former 29.1 27.7
Current 15.3 18.9
Alcohol consumption (%)
410g/day 26.4 27.6
Oral contraceptive use
(% ever)
50.0 61.1
HRT use (% ever)
b 45.7 33.0
BMI¼body mass index; HRT¼hormone replacement therapy.
aAmong parous
women.
bResults among postmenopausal women only.
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also found no association of any of these variables with
endometrial cancer risk within strata of BMI or hormone
replacement use, the two strongest risk factors in our study, or
within strata of menopausal status, which is an important
determinant of body iron levels.
The few previous studies of meat and red meat intake in relation
to endometrial cancer were mainly case–control in type, while a
recent systematic review and meta-analysis has examined the
available evidence in detail (Bandera et al, 2007). The random
effects pooled odds ratio in the meta-analysis of meat intake (7 of
the 10 studies had information on all types of meat combined,
while the remaining 3 had information on ‘meat, unspecified’) and
endometrial cancer was 1.26, 95% CI 1.03–1.54, per 100g/day
increase in intake. However, there was a large degree of
heterogeneity between the individual study results. Results of the
meta-analysis of red meat intake were somewhat stronger: pooled
odds ratio for the seven case–control studies was 1.51, 95% CI
1.19–1.93 per 100g/day increase in intake.
Only one cohort study of 23000 postmenopausal women
followed for 7 years had adequate numbers of cases (216) to
permit a conventional analysis (Zheng et al, 1995). Relative risks
for both total meat intake and red meat intake were 1.0 and 1.1 for
the intermediate and extreme tertiles, respectively, relative to the
lowest tertile (no CIs were reported) (Zheng et al, 1995). Our
results for total meat and red meat intake are consistent with those
from this previous cohort study. Inclusion of the results of these
two cohort studies in a meta-analysis would be expected to
somewhat reduce the summary estimate of the relative risk for red
meat intake and endometrial cancer.
Table 2 Multivariate-adjusted HR and 95% CI for the association of intake of iron-related variables with risk of incident endometrial cancer
Factor Cases Person-years
Age-adjusted
HR (95% CI)
Multivariate-adjusted
HR
a (95% CI)
All meat (g/day)
o157.71 92 115817 1.00 (reference) 1.00 (reference)
157.71–o187.83 98 114520 1.09 (0.82-1.45) 1.11 (0.83–1.48)
187.83–o217.29 70 113712 0.79 (0.58–1.08) 0.83 (0.60–1.15)
217.29–o257.86 86 110471 1.00 (0.74–1.34) 0.93 (0.68–1.27)
X257.86 78 104987 0.96 (0.71–1.30) 0.83 (0.60–1.15)
P for trend 0.58 0.14
Red meat (g/day)
o48.49 87 113996 1.00 (reference) 1.00 (reference)
48.49–o66.33 91 113187 1.07 (0.79–1.43) 1.14 (0.84–1.55)
66.33–o83.47 85 112695 1.02 (0.75–1.37) 1.08 (0.79–1.47)
83.47–o108.99 95 110401 1.16 (0.87–1.56) 1.26 (0.93–1.72)
108.99+ 64 104224 0.82 (0.60–1.14) 0.86 (0.61–1.22)
P for trend 0.50 0.75
Total Iron (mg/day)
o11.90 82 115624 1.00 (reference) 1.00 (reference)
11.90–o12.90 104 114890 1.27 (0.95–1.70) 1.21 (0.90–1.63)
12.90–o13.82 86 113925 1.05 (0.77–1.42) 1.08 (0.79–1.48)
13.82–o14.99 83 111752 1.03 (0.76–1.39) 0.95 (0.69–1.32)
X14.99 71 104795 0.93 (0.68–1.28) 0.90 (0.64–1.26)
P for trend 0.31 0.22
Meat iron (mg/day)
o3.40 91 116322 1.00 (reference) 1.00 (reference)
3.40–o4.23 99 114992 1.11 (0.83–1.47) 1.08 (0.80–1.45)
4.23–o5.02 81 113035 0.94 (0.70–1.27) 0.94 (0.69–1.29)
5.02–o6.11 86 111567 1.00 (0.75–1.34) 0.98 (0.72–1.34)
X6.11 69 104084 0.87 (0.64–1.19) 0.79 (0.57–1.11)
P for trend 0.29 0.16
Heme iron (mg/day)
o1.58 93 115820 1.00 (reference) 1.00 (reference)
1.58–o1.99 96 114575 1.06 (0.80–1.41) 1.10 (0.82–1.48)
1.99–o2.40 86 113127 0.98 (0.73–1.31) 1.00 (0.74–1.37)
2.40–o2.95 82 111776 0.94 (0.70–1.27) 0.98 (0.72–1.35)
42.95 69 104703 0.85 (0.62–1.16) 0.82 (0.59–1.16)
P for trend 0.22 0.22
Non-heme iron (mg/day)
o14.25 76 113128 1.00 (reference) 1.00 (reference)
14.25–o21.02 99 113563 1.29 (0.96–1.74) 1.33 (0.97–1.80)
21.02–o28.74 96 114442 1.23 (0.91–1.66) 1.25 (0.91–1.71)
28.74–40.30 68 112566 0.87 (0.63–1.21) 0.86 (0.61–1.22)
40.30+ 87 107287 1.16 (0.85–1.57) 1.10 (0.79–1.53)
P for trend 0.76 0.50
CI¼confidence interval; HR¼hazard ratio.
aAdjusted for age (continuous); body mass index (kgm
 2) (continuous); menopausal status (pre-, peri-, postmenopausal); parity
(nulliparous, 1–2, 3–4, 5+ live births); age at menarche (continuous); duration of oral contraceptive use (never, 1–11 months, 12–35 months, 36–71 months, 72+ months);
duration of hormone replacement use (never, 1–11 months,12–59 months, 60–119 months, 120+ months); total calorie intake (continuous); intake of raw vegetables
(continuous); alcohol intake (in g/day–continuous); physical activity (vigorous, other); and education (three levels).
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relation to endometrial cancer risk. However, a case–control study
from Sweden (Terry et al, 2002a) reported that use of iron
supplements appeared to increase risk (OR ¼1.7, 95% CI 0.9–3.3,
P for trend ¼0.03). We did not have information on use of iron
supplements, which represent an important contributor to total
iron intake in users. In a cohort study of New York City women
enrolled from 1985 to 1991 (Kato et al, 1999), 69% of participants
reported use of vitamin/mineral supplements, which accounted for
38% of total iron intake. Other surveys carried out in the United
States in the 1980s indicate that over 40% of women currently
consumed one or more vitamin or mineral supplements, and fewer
than half of users reported taking a preparation containing iron
(Stewart et al, 1985). We were unable to find similar data
pertaining to Canada in the early 1980s, when enrolment in NBSS
took place. While iron supplements contribute to total iron intake,
most formulations do not contribute to haem iron intake
(Frykman et al, 1994).
The present study has a number of strengths. We had a relatively
large number of incident endometrial cancer cases and were able
to control for known risk factors, including BMI, hormone
replacement therapy, parity, oral contraceptive use, and physical
activity, as well as other covariates, including total caloric intake.
In agreement with previous studies, in our data BMI and duration
of hormone replacement use showed dose–response relationships
with endometrial cancer risk, and parity and duration of oral
contraceptive use were inversely associated with risk. Our
questionnaire included 22 questions on different types of meat
and meat-containing dishes, and we used two different approaches
to estimating haem iron intake, both of which yielded similar
results. Finally, the results were unchanged when cases diagnosed
during the first 3 years of follow-up were excluded from the
analysis.
A number of limitations should also be mentioned. Only
baseline exposure data were available, and dietary and other
exposures may have changed over the 16 year average follow-up
period, resulting in some degree of non-differential misclassifica-
tion of exposure, which would reduce the power to detect an effect
of the variables under study. Also, we also did not have
information on a personal history of diabetes.
In summary, in this large prospective cohort study, we found no
suggestion of an association of intake of meat, red meat, or dietary
intake of iron or haem iron assessed at baseline with risk of
subsequent endometrial cancer. Furthermore, we found no
associations of any of these variables within strata of established
risk factors. Future studies should improve on the assessment of
iron and haem intake by using repeated measurements and
obtaining information on use of iron-containing supplements and
a personal history of metabolic syndrome and diabetes.
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